Amarantus' LymPro Could Be A Game-Changer For Alzh
Post# of 30013
![](/assets/46931549/no_avatar_available_thumb.jpg)
Apr. 17, 2013 10:35 AM
http://seekingalpha.com/article/1347691-amara...-diagnosis
Quote:
"We believe this reinforces the need and desire for early-stage detection, and the potential multi-hundred million dollar opportunity that LymPro represents. We note that LymPro has completed two phase I clinical studies in over 160 patients, showing 98% sensitivity and 96% specificity for Alzheimer's disease diagnosis. These statistics compared favorably to the sensitivity (82-92%) and specificity (95%) of Amyvid, as outlined in the package insert."
I'm assuming above data results are from V-1 only...with V-2 data yet tobe revealed...
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)